PPB - Services

Complaints, Feedback and Enquiry

Pharmacovigilance Summary Report: October-December 2021 (Q2)

[featured_image]
  • Version
  • Download 3
  • File Size 608.75 KB
  • File Count 1
  • Create Date June 23, 2022
  • Last Updated June 23, 2022

Pharmacovigilance Summary Report: October-December 2021 (Q2)

The Pharmacy and Poisons Board is the Drug Regulatory Authority established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The Board regulates the Practice of Pharmacy and the manufacture and trade in drugs and poisons.

PPB has 4 directorates of which the Directorate of Medicines Information and Pharmacovigilance (MIPV) is responsible for Pharmacovigilance, Post-Market Surveillance, Clinical Trials & Medicines Information activities. MIPV shares quarterly pharmacovigilance reports with stakeholders to serve as a feedback mechanism and also encourage all stakeholders to report.

Since the introduction of PV in Kenya, a total of 15,271 individual case safety reports has been submitted to the global data reports 29,758,222 (0.05%).

Attached Files

FileAction
PV Summary Reports Q2_2021_2022.pdfDownload

Author

ppb_admin

Leave a comment

Your email address will not be published.